1. Assessing metabolic syndrome in people with ID (intellectual disabilities) on antipsychotic medication. (30th July 2014) Authors: Carballedo, A.; Doran, A.; Doyle, M.; Flavin, S.; Tyrrel, J.; Kelly, F.; Guerin, S.; Dodd, P. Journal: Irish journal of psychological medicine Issue: Volume 31:Number 4(2014:Dec.) Page Start: 245 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Efficacy and safety of guselkumab in patients with psoriasis who have an inadequate response to ustekinumab: results of the randomized, double‐blind, phase III NAVIGATE trial. (10th October 2017) Authors: Langley, R.G.; Tsai, T.‐F.; Flavin, S.; Song, M.; Randazzo, B.; Wasfi, Y.; Jiang, J.; Li, S.; Puig, L. Journal: British journal of dermatology Issue: Volume 178:Number 1(2018) Page Start: 114 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Efficacy and safety of guselkumab in patients with psoriasis who have an inadequate response to ustekinumab: results of the randomized, double‐blind, phase III NAVIGATE trial. (1st January 2018) Authors: Langley, R.G.; Tsai, T.‐F.; Flavin, S.; Song, M.; Randazzo, B.; Wasfi, Y.; Jiang, J.; Li, S.; Puig, L. Journal: British journal of dermatology Issue: Volume 178:Number 1(2018) Page Start: e69 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Efficacy and safety of guselkumab in patients with psoriasis who have an inadequate response to ustekinumab: results of the randomized, double‐blind, phase III NAVIGATE trial. (1st January 2018) Authors: Langley, R.G.; Tsai, T.‐F.; Flavin, S.; Song, M.; Randazzo, B.; Wasfi, Y.; Jiang, J.; Li, S.; Puig, L. Journal: British journal of dermatology Issue: Volume 178:Number 1(2018) Page Start: 114 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Efficacy and safety of guselkumab in patients with psoriasis who have an inadequate response to ustekinumab: results of the randomized, double‐blind, phase III NAVIGATE trial. (22nd January 2018) Authors: Langley, R.G.; Tsai, T.‐F.; Flavin, S.; Song, M.; Randazzo, B.; Wasfi, Y.; Jiang, J.; Li, S.; Puig, L. Journal: British journal of dermatology Issue: Volume 178:Number 1(2018) Page Start: e69 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Guselkumab 对使用优特克单抗疗效不佳的银屑病患者的有效性和安全性:随机、双盲 III 期 NAVIGATE 试验结果. (1st January 2018) Authors: Langley, R.G.; Tsai, T.‐F.; Flavin, S.; Song, M.; Randazzo, B.; Wasfi, Y.; Jiang, J.; Li, S.; Puig, L. Journal: British journal of dermatology Issue: Volume 178:Number 1(2018) Page Start: e88 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Guselkumab 对使用优特克单抗疗效不佳的银屑病患者的有效性和安全性:随机、双盲 III 期 NAVIGATE 试验结果. (22nd January 2018) Authors: Langley, R.G.; Tsai, T.‐F.; Flavin, S.; Song, M.; Randazzo, B.; Wasfi, Y.; Jiang, J.; Li, S.; Puig, L. Journal: British journal of dermatology Issue: Volume 178:Number 1(2018) Page Start: e88 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗